+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Overactive Bladder Treatment Market Research Report by Drug Therapy (Anticholinergic, BOTO, and Darifenacin), Disease Type, Distribution, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 226 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4968613
UP TO OFF until Dec 31st 2022
The Global Overactive Bladder Treatment Market size was estimated at USD 4,243.20 million in 2021, USD 4,390.23 million in 2022, and is projected to grow at a CAGR 3.64% to reach USD 5,259.14 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Overactive Bladder Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Therapy, the market was studied across Anticholinergic, BOTO, Darifenacin, Fesoterodine, Mirabegron, Neurostimulation, Oxybutynin, and Solifenacin.
  • Based on Disease Type, the market was studied across Idiopathic Bladder Overactivity and Neurogenic Bladder Overactivity.
  • Based on Distribution, the market was studied across Hospital & Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Overactive Bladder Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Overactive Bladder Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Overactive Bladder Treatment Market, including Allergan plc, Apotex Inc., Aurobindo Pharma Limited, Endo International plc., Hisamitsu Pharmaceutical Co., Inc., Intas Biopharmaceuticals, Johnson & Johnson, Medtronic plc, Mylan N.V., and Sanofi S.A..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Overactive Bladder Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Overactive Bladder Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Overactive Bladder Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Overactive Bladder Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Overactive Bladder Treatment Market?
6. What is the market share of the leading vendors in the Global Overactive Bladder Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Overactive Bladder Treatment Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth in Number of People with Overactive Bladder (Oab) Symptoms
5.1.1.2. Increase in Aging Population
5.1.2. Restraints
5.1.2.1. Adverse Effects and Risk Associated with Overactive Bladder Treatment
5.1.3. Opportunities
5.1.3.1. Overactive Bladder Clinical Research Trials and Pipeline
5.1.4. Challenges
5.1.4.1. Limited Awareness of Oab Condition
5.2. Cumulative Impact of COVID-19
6. Overactive Bladder Treatment Market, by Drug Therapy
6.1. Introduction
6.2. Anticholinergic
6.3. Boto
6.4. Darifenacin
6.5. Fesoterodine
6.6. Mirabegron
6.7. Neurostimulation
6.8. Oxybutynin
6.9. Solifenacin
7. Overactive Bladder Treatment Market, by Disease Type
7.1. Introduction
7.2. Idiopathic Bladder Overactivity
7.3. Neurogenic Bladder Overactivity
8. Overactive Bladder Treatment Market, by Distribution
8.1. Introduction
8.2. Hospital & Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Americas Overactive Bladder Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Overactive Bladder Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Overactive Bladder Treatment Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. Fpnv Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Allergan plc
13.2. Apotex Inc.
13.3. Aurobindo Pharma Limited
13.4. Endo International plc.
13.5. Hisamitsu Pharmaceutical Co., Inc.
13.6. Intas Biopharmaceuticals
13.7. Johnson & Johnson
13.8. Medtronic plc
13.9. Mylan N.V.
13.10. Sanofi S.A.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET DYNAMICS
FIGURE 8. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2021 VS 2027 (%)
FIGURE 9. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2027
FIGURE 11. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ANTICHOLINERGIC, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ANTICHOLINERGIC, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY BOTO, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY BOTO, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DARIFENACIN, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DARIFENACIN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY FESOTERODINE, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY FESOTERODINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY MIRABEGRON, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY MIRABEGRON, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROSTIMULATION, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY OXYBUTYNIN, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY OXYBUTYNIN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY SOLIFENACIN, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY SOLIFENACIN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2021 VS 2027 (%)
FIGURE 28. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2027
FIGURE 30. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY IDIOPATHIC BLADDER OVERACTIVITY, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY IDIOPATHIC BLADDER OVERACTIVITY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROGENIC BLADDER OVERACTIVITY, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROGENIC BLADDER OVERACTIVITY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 35. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2027
FIGURE 37. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY HOSPITAL & HOSPITAL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY HOSPITAL & HOSPITAL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 45. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 47. ARGENTINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. BRAZIL OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. CANADA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. MEXICO OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 53. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY STATE, 2027
FIGURE 55. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 57. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 58. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 59. AUSTRALIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. CHINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. INDIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. INDONESIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. JAPAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. MALAYSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. PHILIPPINES OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. SINGAPORE OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. SOUTH KOREA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. TAIWAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. THAILAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 73. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 74. FRANCE OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. GERMANY OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. ITALY OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. NETHERLANDS OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. QATAR OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. RUSSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. SAUDI ARABIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. SOUTH AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. SPAIN OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. UNITED ARAB EMIRATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. UNITED KINGDOM OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 86. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 87. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL OVERACTIVE BLADDER TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ANTICHOLINERGIC, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ANTICHOLINERGIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ANTICHOLINERGIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ANTICHOLINERGIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ANTICHOLINERGIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY BOTO, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY BOTO, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY BOTO, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY BOTO, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY BOTO, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DARIFENACIN, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DARIFENACIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DARIFENACIN, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DARIFENACIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DARIFENACIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY FESOTERODINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY FESOTERODINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY FESOTERODINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY FESOTERODINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY FESOTERODINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY MIRABEGRON, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY MIRABEGRON, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY MIRABEGRON, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY MIRABEGRON, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY MIRABEGRON, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROSTIMULATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROSTIMULATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROSTIMULATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROSTIMULATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY OXYBUTYNIN, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY OXYBUTYNIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY OXYBUTYNIN, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY OXYBUTYNIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY OXYBUTYNIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY SOLIFENACIN, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY SOLIFENACIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY SOLIFENACIN, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY SOLIFENACIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY SOLIFENACIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY IDIOPATHIC BLADDER OVERACTIVITY, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY IDIOPATHIC BLADDER OVERACTIVITY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY IDIOPATHIC BLADDER OVERACTIVITY, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY IDIOPATHIC BLADDER OVERACTIVITY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY IDIOPATHIC BLADDER OVERACTIVITY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROGENIC BLADDER OVERACTIVITY, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROGENIC BLADDER OVERACTIVITY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROGENIC BLADDER OVERACTIVITY, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROGENIC BLADDER OVERACTIVITY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY NEUROGENIC BLADDER OVERACTIVITY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 58. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY HOSPITAL & HOSPITAL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 59. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY HOSPITAL & HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY HOSPITAL & HOSPITAL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 61. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY HOSPITAL & HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY HOSPITAL & HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 64. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 66. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 69. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 71. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 76. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 77. AMERICAS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 78. ARGENTINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. ARGENTINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 80. ARGENTINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 81. ARGENTINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 82. BRAZIL OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. BRAZIL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 84. BRAZIL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 85. BRAZIL OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 86. CANADA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. CANADA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 88. CANADA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 89. CANADA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 90. MEXICO OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. MEXICO OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 92. MEXICO OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 93. MEXICO OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 94. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 96. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 97. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 98. UNITED STATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 99. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 101. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 102. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 103. ASIA-PACIFIC OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 104. AUSTRALIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. AUSTRALIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 106. AUSTRALIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 107. AUSTRALIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 108. CHINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 109. CHINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 110. CHINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 111. CHINA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 112. INDIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. INDIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 114. INDIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 115. INDIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 116. INDONESIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. INDONESIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 118. INDONESIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 119. INDONESIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 120. JAPAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 121. JAPAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 122. JAPAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 123. JAPAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 124. MALAYSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 125. MALAYSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 126. MALAYSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 127. MALAYSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 128. PHILIPPINES OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. PHILIPPINES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 130. PHILIPPINES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 131. PHILIPPINES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 132. SINGAPORE OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. SINGAPORE OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 134. SINGAPORE OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 135. SINGAPORE OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 136. SOUTH KOREA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 137. SOUTH KOREA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 138. SOUTH KOREA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 139. SOUTH KOREA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 140. TAIWAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 141. TAIWAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 142. TAIWAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 143. TAIWAN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 144. THAILAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 145. THAILAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 146. THAILAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 147. THAILAND OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 153. FRANCE OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 154. FRANCE OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 155. FRANCE OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 156. FRANCE OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 157. GERMANY OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 158. GERMANY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 159. GERMANY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 160. GERMANY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 161. ITALY OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 162. ITALY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 163. ITALY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 164. ITALY OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 165. NETHERLANDS OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 166. NETHERLANDS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 167. NETHERLANDS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 168. NETHERLANDS OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 169. QATAR OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 170. QATAR OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 171. QATAR OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 172. QATAR OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 173. RUSSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 174. RUSSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 175. RUSSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 176. RUSSIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 177. SAUDI ARABIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 178. SAUDI ARABIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 179. SAUDI ARABIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 180. SAUDI ARABIA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 181. SOUTH AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 182. SOUTH AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 183. SOUTH AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 184. SOUTH AFRICA OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 185. SPAIN OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 186. SPAIN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 187. SPAIN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 188. SPAIN OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 193. UNITED KINGDOM OVERACTIVE BLADDER TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 194. UNITED KINGDOM OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DRUG THERAPY, 2019-2027 (USD MILLION)
TABLE 195. UNITED KINGDOM OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 196. UNITED KINGDOM OVERACTIVE BLADDER TREATMENT MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 197. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 198. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 199. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 200. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET RANKING
TABLE 201. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 202. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET MERGER & ACQUISITION
TABLE 203. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 204. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 205. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET INVESTMENT & FUNDING
TABLE 206. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 207. GLOBAL OVERACTIVE BLADDER TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • Allergan plc
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Endo International plc.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Intas Biopharmaceuticals
  • Johnson & Johnson
  • Medtronic plc
  • Mylan N.V.
  • Sanofi S.A.

Methodology

Loading
LOADING...